Fact CheckerSign in

NCT07231510Recruiting

Chlordecone Exposure and Female Fertility

KARU-FERTIL: Chlordecone Exposure and Female Fertility

Source: ClinicalTrials.gov · Last updated 17 Nov 2025

Brief summary (registry, in English)

Chlordecone is an organochlorine pesticide used in the French West Indies (FWI) from 1972 to 1993 to control the banana root borer. Due to its very long persistence the population continues to be exposed to this chemical through their food consumptions. Although, chlordecone have been associated in animal study impairment of ovarian reserve, to date, no study has been published concerning the link between chlordecone exposure and female fertility. The main objective of this project is to study the association between chlordecone exposure and anti-mullerian hormone (AMH) in women consulting for couple infertility in Guadeloupe.

Status (registry)
Recruiting
Study type
Observational
Enrollment
634 (estimated)
First submitted
14 Nov 2025
Start date
26 Jan 2024
Primary completion date
26 Jan 2026
Lead sponsor
Centre Hospitalier Universitaire de la Guadeloupe
NCT number
NCT07231510

What you commit to

  • Study type: Observational
  • Planned participants: 634
  • From 26 Jan 2024 to the primary completion date, 26 Jan 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • Women aged from 18 to 39 years

Other

  • Consulting for couple infertility at the Centre Caribéen de Médecine de la Reproduction (CCMR, Caribbean Center for Reproductive Medicine) of the University Hospital of Guadeloupe
  • Free, informed and written consent

Who the study is looking for

  • Women aged from 18 to 39 years
  • Consulting for couple infertility at the Centre Caribéen de Médecine de la Reproduction (CCMR, Caribbean Center for Reproductive Medicine) of the University Hospital of Guadeloupe
  • Free, informed and written consent

Age in the registry: 18 years to 39 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHU de la Guadeloupe
Coordinator of this site? Confirm its status
Pointe-à-PitreGuadeloupeRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.